{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:10:40Z","timestamp":1794618640053,"version":"4.9.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH-P60-AR047782"],"award-info":[{"award-number":["NIH-P60-AR047782"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH-K24-AR060231"],"award-info":[{"award-number":["NIH-K24-AR060231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/rheumatology\/key179","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T11:08:44Z","timestamp":1528369724000},"page":"1933-1937","source":"Crossref","is-referenced-by-count":30,"title":["Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial"],"prefix":"10.1093","volume":"57","author":[{"given":"Agnes","family":"Zak","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Corrigan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Bitton","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Yale School of Medicine, West Haven Veterans Affairs Health System, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Harrold","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"key\n\t\t\t\t20181024035315962_key179-B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20181024035315962_key179-B2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2011-200274","article-title":"A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry","volume":"71","author":"Schipper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20181024035315962_key179-B3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181024035315962_key179-B4","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/rheumatology\/keq195","article-title":"Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome","volume":"49","author":"Schipper","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20181024035315962_key179-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21710","article-title":"The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis","volume":"21","author":"Wailoo","year":"2017","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20181024035315962_key179-B6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/acr.21872","article-title":"Reply: to PMID 22473917","volume":"65","author":"Singh","year":"2013","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20181024035315962_key179-B7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.33380","article-title":"Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations","volume":"64","author":"Harrold","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20181024035315962_key179-B8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/acr.22108","article-title":"Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity","volume":"66","author":"Tymms","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t20181024035315962_key179-B9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.40111","article-title":"Implementation of treat-to-target in rheumatoid arthritis through a learning collaborative: results of a randomized controlled trial","volume":"69","author":"Solomon","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20181024035315962_key179-B10","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/ar4099","article-title":"Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort","volume":"14","author":"Vermeer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20181024035315962_key179-B11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/art.22719","article-title":"Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients\u2019 treatment choices","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20181024035315962_key179-B12","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/acr.22902","article-title":"Patient-physician discordance in global assessment in rheumatoid arthritis: a systematic literature review with meta-analysis","volume":"68","author":"Desthieux","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t20181024035315962_key179-B13","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/art.34543","article-title":"Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity","volume":"64","author":"Studenic","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20181024035315962_key179-B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pec.2014.11.011","article-title":"Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis","volume":"98","author":"Meyfroidt","year":"2015","journal-title":"Patient Educ Couns"},{"key":"key\n\t\t\t\t20181024035315962_key179-B15","doi-asserted-by":"crossref","first-page":"e000502","DOI":"10.1136\/rmdopen-2017-000502","article-title":"Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial","volume":"3","author":"Ter Wee","year":"2017","journal-title":"RMD Open"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/11\/1933\/26146542\/key179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:59:35Z","timestamp":1720346375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/11\/1933\/5049433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,7,5]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key179","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,7,5]]}}}